News

We are pleased to announce that Weill Cornell Medical Center with NewYork-Presbyterian has been designated as a NORD Rare Disease Center of Excellence, becoming one of 40 U.S. academic medical centers selected to be a part of the first-of-it-kind national network of U.S. medical institutions dedicated to diagnosing, treating, and researching all rare diseases.  The network is led by the National Organization for Rare Disorders (NORD) and is designed to foster knowledge sharing between rare disease experts across the country to help meet the unmet needs of more than 25 million Americans living with a rare disease. Omar Abdul-Rahman, M.D., Chief of Medical Genetics in the Department of Pediatrics, will be the director of the Rare Disease Center of Excellence at NewYork-Presbyterian/Weill Cornell Medical Center. 

This article was originally posted in the NewYork-Presbyterian newsroom

NewYork-Presbyterian Hospital has been recognized as the 2023-2024 #1 children’s hospital in New York by U.S. News & World Report. This is the 17th year in a row that the Hospital has ranked among the best children’s hospitals in the nation.

NewYork-Presbyterian Hospital was the only hospital in New York to rank among the top 50 hospitals across all 10 pediatrics specialties evaluated. The Hospital ranked in the top 10 in pediatric diabetes & endocrinology, and in the top 20 in pediatric cardiology & heart surgery, pediatric neurology & neurosurgery, and neonatology.

NewYork-Presbyterian provides pediatric care in every area of medicine at two major sites: NewYork-Presbyterian Morgan Stanley Children’s Hospital and NewYork-Presbyterian Komansky Children’s Hospital. NewYork-Presbyterian is the nation’s only hospital affiliated with two world-class medical schools, Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine.


On June 20th, the Department of Pediatrics hosted its annual Department Awards Celebration to recognize colleagues for their work in improving children's health. The award ceremony acknowledged the exceptional contributions and dedicated efforts of department members in various areas, including clinical care, education, research and administration.

Congratulations to the recipients of the 2023 Department of Pediatrics Awards!

The Department of Pediatrics and Gale and Ira Drukier Institute at Weill Cornell Medicine hosted its second annual Pediatrics Research Day on June 6th. This special event, organized by Pediatrics and Drukier Faculty Organization Committees, celebrated the advancements and contributions made by our faculty and trainees in the field of children's health research.

The Pediatrics Research Day showcased a diverse range of research disciplines, including basic science, clinical studies, translational research, quality improvement, and educational research. Our faculty and trainees presented their findings through oral abstracts and poster presentations.

The event began with welcoming remarks from Dr. Sallie Permar, Chair of Pediatrics, and Dr. Virginia Pascual, Director of the Gale and Ira Drukier Institute. Dr. Sujit Sheth, Vice Chair of Clinical Research, provided an overview of the ongoing research activities within our department and valuable information about the resources available to our researchers.

Cancers often release molecules into the bloodstream that pathologically alter the liver, shifting it to an inflammatory state, causing fat buildup and impairing its normal detoxifying functions, according to a study from investigators at Weill Cornell Medicine. This discovery illuminates one of cancer’s more insidious survival mechanisms and suggests the possibility of new tests and drugs for detecting and reversing this process.

Jake Larose is a now healthy 13-year-old boy who experienced a severe medical journey after developing hemolytic uremic syndrome from eating a hamburger in March 2014. His condition rapidly progressed, leading to acute renal failure, peritonitis, bowel perforation, severe septic shock, and acute respiratory failure. Throughout his stay in the Pediatric Intensive Care Unit (PICU) at NewYork-Presbyterian Komansky Children’s Hospital, Jake received extensive multidisciplinary care and rehabilitation. Despite experiencing delirium and hallucinations during his ICU stay, Jake made a remarkable recovery and was eventually discharged home. Though he still requires ongoing medical care, nearly a decade later, Jake is doing well. 

Dr. Zachary Grinspan, Interim Division Chief of pediatric neurology at Weill Cornell Medicine and Director of the Pediatric Epilepsy Program, has been awarded an R01 from the National Institute of Neurological Disorders and Stroke for his study, “NS-PEACE Neonatal Seizures -Predicting Epilepsy and Assessing Comparative Effectiveness.” The study aims to improve the care of newborns who experience seizures and their subsequent outcomes and predict and prevent epilepsy in high-risk individuals.

Neonatal seizures occur once per 1000 live births and are associated with the subsequent development of epilepsy, cerebral palsy, and intellectual disability. This study will address three questions related to the management of acute symptomatic neonatal seizures. First, it will compare the effectiveness of two anti-seizure medications, levetiracetam and phenytoin/fosphenytoin, to determine which is the best second-line medication. Second, it will examine whether the use of certain medications, like oxcarbazepine, affects the risk of infantile spasms syndrome. Finally, it will validate a published epilepsy prediction rule to determine which infants will develop epilepsy after leaving the neonatal intensive care unit.  

Full article posted in WCM Newsroom

Dr. James C. Lo, an associate professor of medicine and Dr. Lisa G. Roth, an associate professor of pediatrics, both from Weill Cornell Medicine, were elected members of the American Society for Clinical Investigation (ASCI) for 2023.

Election into the ASCI, which represents excellence across the breadth of academic medicine, is a milestone for physician-scientists. The nonprofit medical honor society, which is comprised of more than 3,000 physician-scientists from all medical specialties, recognizes and supports the scientific efforts, educational needs and clinical aspirations of physician-scientists to improve the health of all people. 

Congratulations to Dr. Zoltan Antal, chief of the Division of Pediatric Endocrinology and director of the Pediatric Diabetes Program, on receiving the Weill Cornell Medicine Marie Metoyer, M.D. Award. The award is given to a current faculty member or Weill Cornell Medical College alumnus who epitomizes the legacy of Dr. Metoyer, the first Black woman to graduate from Weill Cornell Medicine who valued healing and community engagement. The award honors those who have gone above and beyond to serve underprivileged communities in an unorthodox manner.

Weill Cornell Medicine honored nearly a dozen faculty, students and staff who exemplify excellence in diversity, equity and inclusion for their commitment to fostering inclusivity in academic medicine on April 25th. Read more.

This article was originally posted in the NORD newsroom.

Washington, DC, May 4, 2023— Today, the National Organization for Rare Disorders (NORD) announced the addition of nine new Rare Disease Centers of Excellence, bringing the total number of medical centers in this network to 40 on the day of the 40th anniversary of NORD’s founding.

The nine new NORD Rare Disease Centers of Excellence announced today include:

Pediatrics Weill Cornell Medicine Appointments & Referrals: (646) 962-KIDS (646) 962-5437 Chair's Office: Weill Cornell Medicine 525 E 68th St.
Box 225
New York, NY 10065 (646) 962-5437